Glendale, CALIFORNIA5 Active Studies

Essential Tremor Clinical Trials in Glendale, CALIFORNIA

Find 5 actively recruiting essential tremor clinical trials in Glendale, CALIFORNIA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
2,423
Enrolling

Recruiting Essential Tremor Studies in Glendale

RecruitingGlendale, CALIFORNIANCT04333576

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relationships, sexuality and sexual activity, and mental ...

800 participants
AbbVie
View Study Details
RecruitingGlendale, CALIFORNIANCT06480383

Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

This is a multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo as adjunctive therapy to GAD treatment in ...

705 participants
Intra-Cellular Therapies, Inc.
View Study Details
RecruitingGlendale, CALIFORNIANCT04661358

Fenofibrate for Prevention of DR Worsening

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately s...

560 participants
Jaeb Center for Health Research
View Study Details
RecruitingGlendale, CALIFORNIANCT06315751

Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome

This study is designed to evaluate the efficacy and safety of gemlapodect (NOE-105) on reducing tics associated with Tourette Syndrome (TS) in adults with TS. Adolescents will be enrolled after a sent...

180 participants
Noema Pharma AG
View Study Details
RecruitingGlendale, CALIFORNIANCT06321302

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study. The purpose of this study is to find ou...

178 participants
Boehringer Ingelheim
View Study Details

About Essential Tremor Clinical Trials in Glendale

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 5 essential tremor clinical trials recruiting participants in Glendale, CALIFORNIA. These studies are seeking a combined 2,423 participants. Research is being sponsored by AbbVie, Intra-Cellular Therapies, Inc., Jaeb Center for Health Research and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in Glendale — FAQ

Are there essential tremor clinical trials in Glendale?

Yes, there are 5 essential tremor clinical trials currently recruiting in Glendale, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Glendale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Glendale research site will contact you about next steps.

Are clinical trials in Glendale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Glendale studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 5 active trials in Glendale are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated March 2, 2026 from ClinicalTrials.gov